These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19165669)

  • 1. Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy.
    Carr DB; Tran LT; Brateng DA; Kawamura C; Shofer JB; Karumanchi SA; Easterling TR
    Hypertens Pregnancy; 2009 Feb; 28(1):42-55. PubMed ID: 19165669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia.
    Carr DB; McDonald GB; Brateng D; Desai M; Thach CT; Easterling TR
    Obstet Gynecol; 2001 Dec; 98(6):1109-16. PubMed ID: 11755562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.
    Easterling TR; Brateng D; Schmucker B; Brown Z; Millard SP
    Obstet Gynecol; 1999 May; 93(5 Pt 1):725-33. PubMed ID: 10912975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
    McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
    Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol for prevention of preeclampsia.
    Ellis MR; Kane KY
    J Fam Pract; 1999 Aug; 48(8):580-1. PubMed ID: 10496633
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of pregnancies at risk for hypertensive complications managed using impedance cardiography.
    Chaffin DG; Webb DG
    Am J Perinatol; 2009 Nov; 26(10):717-21. PubMed ID: 19452431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.
    De Paco C; Kametas N; Rencoret G; Strobl I; Nicolaides KH
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):292-300. PubMed ID: 18238965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia.
    Veas CJ; Aguilera VC; Muñoz IJ; Gallardo VI; Miguel PL; González MA; Lamperti LI; Escudero CA; Aguayo CR
    J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1371-7. PubMed ID: 21381877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy.
    McElrath TF; Lim KH; Pare E; Rich-Edwards J; Pucci D; Troisi R; Parry S
    Am J Obstet Gynecol; 2012 Nov; 207(5):407.e1-7. PubMed ID: 22981320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
    Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia.
    Eshkoli T; Holcberg G; Bronfenmacher B; Amash A; Huleihel M; Erez O
    J Matern Fetal Neonatal Med; 2013 Jan; 26(2):116-22. PubMed ID: 22928533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience].
    Stepan H; Schaarschmidt W; Jank A; Verlohren S; Kratzsch J
    Z Geburtshilfe Neonatol; 2010 Dec; 214(6):234-8. PubMed ID: 21207323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
    Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.